Tech Mahindra Recognized as a Leader and Rising Star in ISG Provider Lens™ Study for Life Sciences Digital Services 2024

Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to enterprises across industries, announced that its healthcare and life sciences vertical, has been recognized as a Leader and Rising Star in the ISG Provider Lens™ Study for Life Sciences Digital Services 2024.

The report has recognized Tech Mahindra as a Leader for its transformative approach to clinical trials, which integrates next-gen solutions to optimize study management and enhance patient engagement. Additionally, Tech Mahindra has been recognized as a Rising Star for its innovative platforms that streamline healthcare delivery and personalize patient experiences on a global scale.

Seshan Ramachandran, SVP & Global Delivery Head, HLS, Tech Mahindra, said, “The life sciences industry is undergoing significant transformation driven by next-gen technologies. These changes are creating new opportunities for research, development, and patient care, resulting in improved efficiency and precision. This recognition by ISG further underscores Tech Mahindra's endeavors to develop innovative solutions to enhance customer experience on a global scale.”

Tech Mahindra's platforms, including HealthNxt, Advanced Clinical Platform, GLAMs and Discovery Research are at the forefront of enabling digital transformation across the life sciences value chain. These platforms leverage GenAI capabilities to fast-track drug discovery, improve patient experience, and streamline the supply chain. As part of Tech Mahindra's strategic focus on the healthcare and life sciences sector, the company is making significant investments in GenAI to enhance its capabilities in data-driven insights, workflow automation, and personalized patient care.

Rohan Sinha, Principal Analyst, ISG, said, “Tech Mahindra is positioned as a key player in life sciences digital services, excelling in patient engagement, clinical solutions, and advanced technology integration. Their focus on AI-driven innovation and digital transformation sets the stage for continued leadership in enhancing patient outcomes and streamlining clinical operations. Looking ahead, Tech Mahindra is well-equipped to drive the future of healthcare through strategic investments and a commitment to evolving with market demands.”

In addition, Tech Mahindra's expertise in application maintenance, upgrades, and support for Clinical Trial Management Systems (CTMS) and Clinical Data Management (CDM) applications ensures continuous innovation and efficiency in clinical trials. With this prestigious recognition, the company has further solidified its position as a trusted partner for customers in the life sciences sector, committed to driving innovation, efficiency, and superior patient care through next-gen digital services and solutions.

For more information on how TechM can partner with you to meet your scale at speed imperatives, please visit https://www.techmahindra.com/

Our Social Media Channels Facebook Twitter LinkedIn YouTube